About Polifarma
Polifarma is a company based in Rome (Italy) founded in 1919. It operates as a Direct-to-Consumer (D2C), and Professional Services. Polifarma has completed 1 acquisition, including HENNIG ARZNEIMITTEL. Polifarma offers products and services including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments. Polifarma operates in a competitive market with competitors including AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others.
- Headquarter Rome, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Polifarma Spa
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polifarma
Polifarma offers a comprehensive portfolio of products and services, including Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatments for common central nervous system diseases are provided.
Various products for gastrointestinal treatment are offered by Polifarma.
Ophthalmic treatments are developed through strategic market agreements.
Cardiovascular drugs are established for significant market presence.
Antibiotics and supplements for immune support are provided.
Funding Insights of Polifarma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Polifarma
Polifarma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include HENNIG ARZNEIMITTEL. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Generic drugs are manufactured and supplied by Hennig Arzneimittel.
|
1898 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Polifarma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Polifarma Comparisons
Competitors of Polifarma
Polifarma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Admenta Italia, LaNova Farmaceutici, Velit Biopharma and FL Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| domain | founded_year | HQ Location |
Provides wholesale pharmaceutical sales, retail pharmacies, and industry services in Italy.
|
|
| domain | founded_year | HQ Location |
Company specializes in sales, promotion, and distribution of drugs, medical devices, supplements, and cosmetics
|
|
| domain | founded_year | HQ Location |
Pharmaceutical company that specializes in the development, distributing, and manufacturing of bio and nano pharmaceuticals, medical devices, and food supplements
|
|
| domain | founded_year | HQ Location |
Cannabis raw materials services are provided by FL Group.
|
|
| domain | founded_year | HQ Location |
Italian company specializing in cardiology pharmaceuticals and clinical nutrition products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Polifarma
When was Polifarma founded?
Polifarma was founded in 1919.
Where is Polifarma located?
Polifarma is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
What does Polifarma do?
Polifarma S.p.A. is focused on the development and distribution of pharmaceutical products across various therapeutic areas. Key sectors include central nervous system, gastroenterology, ophthalmology, cardiovascular, and infectious diseases. Solutions are tailored for healthcare professionals and aim to improve quality of life through innovative medicines and research. The company is recognized for its continuous growth and commitment to future-oriented medical advancements.
Who are the top competitors of Polifarma?
Polifarma's top competitors include AmerisourceBergen, FL Group and Velit Biopharma.
What products or services does Polifarma offer?
Polifarma offers Central Nervous System Treatments, Gastroenterology Products, Ophthalmology Solutions, Cardiovascular Medications, and Infectious Disease Treatments.
How many acquisitions has Polifarma made?
Polifarma has made 1 acquisition, including HENNIG ARZNEIMITTEL.